Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones

Status:
Completed

Trial end date:
2008-09-01

Target enrollment:

Participant gender:

Evaluate the safety and systemic absorption of OMS201 following exposure during ureteroscopy.

Phase 1

Omeros Corporation